FDA device listing

NXTAG Respiratory Pathogen Panel

FDA device listing 1947463712 · Luminex Corporation

Key facts

Proprietary names NXTAG Respiratory Pathogen Panel
Owner/operator Luminex Corporation
Owner/operator number 9032042
Premarket submissions K242613
Product codes NXD, OCC, OEM, OEP, OOI, OOU, OTG, OZX, OZY
Device names NXD - Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna, OCC - Respiratory Virus Panel Nucleic Acid Assay System, OEM - Human Metapneumovirus (Hmpv) Rna Assay System, OEP - Influenza A Virus Subtype Differentiation Nucleic Acid Assay, OOI - Real Time Nucleic Acid Amplification System, OOU - Parainfluenza Multiplex Nucleic Acid Assay, OTG - Non-Sars Coronavirus Multiplex Nucleic Acid Assay, OZX - Mycoplasma Pneumoniae Dna Assay System, OZY - Chlamydophila Pneumoniae Dna Assay System
Device class Class II
Classification regulations (21 CFR) 862.2570, 866.3332, 866.3980
Review panels Clinical Chemistry, Microbiology
Registered establishments LUMINEX MOLECULAR DIAGNOSTICS, INC.
Establishment registrations 3002777243
FEI numbers 3002777243
Establishment operations Manufacturer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings